{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T16:08:27Z","timestamp":1789920507920,"version":"4.0.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T00:00:00Z","timestamp":1552003200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Ministry of Human Resource Development (IN) GOI","award":["(No. F. 5-6\/2013-TS.VII)"],"award-info":[{"award-number":["(No. F. 5-6\/2013-TS.VII)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Model"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00894-019-3954-2","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T07:19:25Z","timestamp":1552029565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Molecular docking and dynamic studies of crepiside E beta glucopyranoside as an inhibitor of snake venom PLA2"],"prefix":"10.1007","volume":"25","author":[{"given":"Mala S.","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amjesh","family":"R.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silpa","family":"Bhaskaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphin R.","family":"D.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achuthsankar S.","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhakaran P.","family":"R.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,8]]},"reference":[{"issue":"1","key":"3954_CR1","first-page":"10","volume":"136","author":"AK Mukherjee","year":"2012","unstructured":"Mukherjee AK (2012) Green medicine as a harmonizing tool to antivenom therapy for the clinical management of snakebite: the road ahead. Indian J Med Res 136(1):10","journal-title":"Indian J Med Res"},{"key":"3954_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/781216","volume":"2013","author":"G Sakthivel","year":"2013","unstructured":"Sakthivel G, Dey A, Nongalleima K, Chavali M, Rimal Isaac RS, Singh NS, Deb L (2013) In vitro and in vivo evaluation of polyherbal formulation against Russell\u2019s viper and cobra venom and screening of bioactive components by docking studies. Evid Based Complement Alternat Med 2013:781216","journal-title":"Evid Based Complement Alternat Med"},{"issue":"24","key":"3954_CR3","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1007\/s00018-006-6315-0","volume":"63","author":"DCI Koh","year":"2006","unstructured":"Koh DCI, Armugam A, Jeyaseelan K (2006) Snake venom components and their applications in biomedicine. Cell Mol Life Sci 63(24):3030\u20133041","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"3954_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/ecam\/neh063","volume":"2","author":"DC Lima de","year":"2005","unstructured":"de Lima DC, Alvarez Abreu P, de Freitas CC, Santos DO, Borges RO, dos Santos TC, Mendes Cabral L, Rodrigues CR, Castro HC (2005) Snake venom: any clue for antibiotics and CAM? Evid Based Complement Alternat Med 2(1):39\u201347","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"3954_CR5","first-page":"37","volume":"9","author":"JM Alam","year":"1996","unstructured":"Alam JM, Qasim RASHIDA, Alam SM (1996) Enzymatic activities of some snake venoms from families Elapidae and Viperidae. Pak J Pharm Sci 9(1):37\u201341","journal-title":"Pak J Pharm Sci"},{"issue":"22","key":"3954_CR6","doi-asserted-by":"publisher","first-page":"7235","DOI":"10.1021\/bi00370a070","volume":"25","author":"PE Bougis","year":"1986","unstructured":"Bougis PE, Marchot P, Rochat H (1986) Characterization of Elapidae snake venom components using optimized reverse-phase high-performance liquid chromatographic conditions and screening assays for alpha-neurotoxin and phospholipase A2 activities. Biochemistry 25(22):7235\u20137243","journal-title":"Biochemistry"},{"issue":"1","key":"3954_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1388-1981(00)00105-0","volume":"1488","author":"DA Six","year":"2000","unstructured":"Six DA, Dennis EA (2000) The expanding superfamily of phospholipase A 2 enzymes: classification and characterization. Biochim Biophys Acta Mol Cell Biol Lipids 1488(1):1\u201319","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"3954_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/978-90-481-9295-3_13","volume-title":"Toxins and hemostasis","author":"G Faure","year":"2010","unstructured":"Faure G, Xu H, Saul F (2010) Anticoagulant phospholipases A2 which bind to the specific soluble receptor coagulation factor Xa. Toxins and hemostasis. Springer, Dordrecht, pp 201\u2013217"},{"issue":"11","key":"3954_CR9","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.bbalip.2006.07.011","volume":"1761","author":"RH Schaloske","year":"2006","unstructured":"Schaloske RH, Dennis EA (2006) The phospholipase A 2 superfamily and its group numbering system. Biochim Biophys Acta Mol Cell Biol Lipids 1761(11):1246\u20131259","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"6","key":"3954_CR10","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/0035-9203(89)90311-8","volume":"83","author":"DA Warrell","year":"1989","unstructured":"Warrell DA (1989) Snake venoms in science and clinical medicine 1. Russell\u2019s viper: biology, venom and treatment of bites. Trans R Soc Trop Med Hyg 83(6):732\u2013740","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"10","key":"3954_CR11","doi-asserted-by":"publisher","first-page":"6130","DOI":"10.1021\/cr200085w","volume":"111","author":"EA Dennis","year":"2011","unstructured":"Dennis EA, Cao J, Hsu YH, Magrioti V, Kokotos G (2011) Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem Rev 111(10):6130\u20136185","journal-title":"Chem Rev"},{"key":"3954_CR12","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/978-90-481-9295-3","volume-title":"Toxins and hemostasis: from bench to bedside","author":"RM Kini","year":"2010","unstructured":"Kini RM, Clemetson KJ, Markland FS, McLane MA, Morita T (2010) Toxins and hemostasis: from bench to bedside. Springer, Dordrecht, p 600"},{"issue":"1","key":"3954_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/jmbi.1998.1759","volume":"279","author":"BW Segelke","year":"1998","unstructured":"Segelke BW, Nguyen D, Chee R, Xuong NH, Dennis EA (1998) Structures of two novel crystal forms of Naja naja naja phospholipase A 2 lacking Ca 2+ reveal trimeric packing. J Mol Biol 279(1):223\u2013232","journal-title":"J Mol Biol"},{"key":"3954_CR14","first-page":"173","volume-title":"Handbook of venoms and toxins of reptiles","author":"Z XingDing","year":"2009","unstructured":"XingDing Z, Kini RM, Doley R, Mackessy SP (2009) Snake venom phospholipase A2 enzymes. Handbook of venoms and toxins of reptiles. Taylor and Francis, Boca Raton, pp 173\u2013215"},{"issue":"1","key":"3954_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1107\/S1744309104025503","volume":"61","author":"G Singh","year":"2005","unstructured":"Singh G, Gourinath S, Saravanan K, Sharma S, Bhanumathi S, Betzel C, Srinivasan A, Singh TP (2005) Sequence-induced trimerization of phospholipase A2: structure of a trimeric isoform of PLA2 from common krait (Bungarus caeruleus) at 2.5 \u00c5 resolution. Acta Crystallogr Sect F: Struct Biol Cryst Commun 61(1):8\u201313","journal-title":"Acta Crystallogr Sect F: Struct Biol Cryst Commun"},{"issue":"8","key":"3954_CR16","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.toxicon.2005.02.018","volume":"45","author":"RM Kini","year":"2005","unstructured":"Kini RM (2005) Structure\u2013function relationships and mechanism of anticoagulant phospholipase A 2 enzymes from snake venoms. Toxicon 45(8):1147\u20131161","journal-title":"Toxicon"},{"issue":"Supplement","key":"3954_CR17","doi-asserted-by":"publisher","first-page":"S237","DOI":"10.1194\/jlr.R800033-JLR200","volume":"50","author":"JE Burke","year":"2009","unstructured":"Burke JE, Dennis EA (2009) Phospholipase A2 structure\/function, mechanism, and signaling. J Lipid Res 50(Supplement):S237\u2013S242","journal-title":"J Lipid Res"},{"issue":"3","key":"3954_CR18","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4103\/0253-7613.157117","volume":"47","author":"SM Pore","year":"2015","unstructured":"Pore SM, Ramanand SJ, Patil PT, Gore AD, Pawar MP, Gaidhankar SL, Ghanghas RR (2015) A retrospective study of use of polyvalent anti-snake venom and risk factors for mortality from snake bite in a tertiary care setting. Indian J Pharm 47(3):270","journal-title":"Indian J Pharm"},{"key":"3954_CR19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cbi.2014.06.015","volume":"220","author":"JA Perea\u00f1ez","year":"2014","unstructured":"Perea\u00f1ez JA, Pati\u00f1o AC, N\u00fa\u00f1ez V, Osorio E (2014) The biflavonoid morelloflavone inhibits the enzymatic and biological activities of a snake venom phospholipase A 2. Chem Biol Interact 220:94\u2013101","journal-title":"Chem Biol Interact"},{"issue":"1","key":"3954_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/jmr.2492","volume":"29","author":"V Sivaramakrishnan","year":"2016","unstructured":"Sivaramakrishnan V, Ilamathi M, Ghosh KS, Sathish S, Gowda TV, Vishwanath BS, Rangappa KS, Dhananjaya BL (2016) Virtual analysis of structurally diverse synthetic analogs as inhibitors of snake venom secretory phospholipase A2. J Mol Recognit 29(1):22\u201332","journal-title":"J Mol Recognit"},{"issue":"6","key":"3954_CR21","first-page":"523","volume":"63","author":"V Sankar","year":"2001","unstructured":"Sankar V, Kalirajan R, Sales FSV, Raghuraman S (2001) Anti inflammatory activity of Elephantopus scaber in albino rats. Indian J Pharm Sci 63(6):523","journal-title":"Indian J Pharm Sci"},{"key":"3954_CR22","doi-asserted-by":"publisher","first-page":"S904","DOI":"10.1016\/S2222-1808(12)60289-8","volume":"2","author":"KO Sheeba","year":"2012","unstructured":"Sheeba KO, Wills PJ, Latha BK, Rajalekshmy R, Latha MS (2012) Antioxidant and antihepatotoxic efficacy of methanolic extract of Elephantopus scaber Linn in Wistar rats. Asian Pac J Trop Dis 2:S904\u2013S908","journal-title":"Asian Pac J Trop Dis"},{"issue":"7","key":"3954_CR23","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1080\/10286020.2011.584310","volume":"13","author":"HW Geng","year":"2011","unstructured":"Geng HW, Zhang XL, Wang GC, Yang XX, Wu X, Wang YF, Ye WC, Li YL (2011) Antiviral dicaffeoyl derivatives from Elephantopus scaber. J Asian Nat Prod Res 13(7):665\u2013669","journal-title":"J Asian Nat Prod Res"},{"key":"3954_CR24","first-page":"246","volume":"3","author":"SH Bhusan","year":"2012","unstructured":"Bhusan SH, Ranjan SS, Subhangankar N, Rakesh S, Amrita B (2012) Nephroprotective activity of ethanolic extract of Elephantopus scaber leaves on albino rats. Int Res J Pharm 3:246\u2013250","journal-title":"Int Res J Pharm"},{"issue":"4","key":"3954_CR25","first-page":"15","volume":"4","author":"G Rao","year":"2012","unstructured":"Rao G, Rao YV, Pavani S, Dasari VP (2012) Qualitative and quantitative phytochemical screening and in vitro anti oxidant and anti microbial activities of Elephantopus scaber Linn. Recent Res Sci Technol 4(4):15\u201320","journal-title":"Recent Res Sci Technol"},{"issue":"3","key":"3954_CR26","doi-asserted-by":"publisher","first-page":"398","DOI":"10.4103\/0253-7613.96347","volume":"44","author":"R Sagar","year":"2012","unstructured":"Sagar R, Sahoo HB (2012) Evaluation of antiasthmatic activity of ethanolic extract of Elephantopus scaber L. leaves. Indian J Pharm 44(3):398","journal-title":"Indian J Pharm"},{"issue":"2","key":"3954_CR27","first-page":"551","volume":"2","author":"K Aabid","year":"2011","unstructured":"Aabid K, Arun P, Mukesh P, Singh BP (2011) Evaluation of anthelmintic property of alcoholic and aqueous extract of leaves of a Elephantopus scaber Linn. Int J Pharm Life Sci 2(2):551\u2013553","journal-title":"Int J Pharm Life Sci"},{"issue":"21","key":"3954_CR28","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1002\/pmic.201300152","volume":"13","author":"GR Yan","year":"2013","unstructured":"Yan GR, Tan Z, Wang Y, Xu ML, Yu G, Li Y, He QY (2013) Quantitative proteomics characterization on the antitumor effects of isodeoxyelephantopin against nasopharyngeal carcinoma. Proteomics 13(21):3222\u20133232","journal-title":"Proteomics"},{"issue":"2","key":"3954_CR29","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3923\/jbs.2007.433.437","volume":"7","author":"P Daisy","year":"2007","unstructured":"Daisy P, Rayan NA, Rajathi D (2007) Hypoglycemic and other related effects of Elephantopus scaber extracts on alloxan induced diabetic rats. J Biol Sci 7(2):433\u2013437","journal-title":"J Biol Sci"},{"issue":"6","key":"3954_CR30","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0031-9422(00)00229-6","volume":"55","author":"WB Mors","year":"2000","unstructured":"Mors WB, Do Nascimento MC, Pereira BMR, Pereira NA (2000) Plant natural products active against snake bite\u2014the molecular approach. Phytochemistry 55(6):627\u2013642","journal-title":"Phytochemistry"},{"key":"3954_CR31","first-page":"13","volume":"5","author":"VB Sandeep","year":"2012","unstructured":"Sandeep VB, Dilip KJ (2012) Profile of medicinal plants with anti ophidian property. J Pharm Sci Innov 5:13\u201320","journal-title":"J Pharm Sci Innov"},{"issue":"13","key":"3954_CR32","first-page":"1212","volume":"3","author":"WY Ho","year":"2009","unstructured":"Ho WY, Ky H, Yeap SK, Rahim RA, Omar AR, Ho CL, Alitheen NB (2009) Traditional practice, bioactivities and commercialization potential of Elephantopus scaber Linn. J Med Plant Res 3(13):1212\u20131221","journal-title":"J Med Plant Res"},{"key":"3954_CR33","unstructured":"ACD\/Structure Elucidator (2012) 2012 Free version. Advanced Chemistry Development, Inc., Toronto. www.acdlabs.com"},{"key":"3954_CR34","volume-title":"LigPrep, version 3","author":"Schr\u00f6dinger Release 2015-3","year":"2015","unstructured":"Schr\u00f6dinger Release 2015-3 (2015) LigPrep, version 3, vol 5. Schr\u00f6dinger, LLC, New York"},{"key":"3954_CR35","volume-title":"QikProp, version 3.2","author":"Small-Molecule Drug Discovery Suite 2016-3","year":"2016","unstructured":"Small-Molecule Drug Discovery Suite 2016-3 (2016) QikProp, version 3.2. Schr\u00f6dinger, LLC, New York"},{"key":"3954_CR36","volume-title":"Discovery studio modeling environment","author":"Accelrys Software Inc.","year":"2007","unstructured":"Accelrys Software Inc. (2007) Discovery studio modeling environment. Accelrys Software Inc., San Diego"},{"key":"3954_CR37","doi-asserted-by":"crossref","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The Protein Data Bank. Nucleic Acids Res 28:235\u2013242. URL: www.rcsb.org\/pdb","DOI":"10.1093\/nar\/28.1.235"},{"key":"3954_CR38","unstructured":"Schr\u00f6dinger L (2010) PyMOL: the PyMOL molecular graphics system"},{"issue":"3","key":"3954_CR39","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"GM Sastry","year":"2013","unstructured":"Sastry GM, Adzhigirey M, Day T, Annabhimoju R, Sherman W (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 27(3):221\u2013234","journal-title":"J Comput Aided Mol Des"},{"issue":"16","key":"3954_CR40","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1002\/jcc.20292","volume":"26","author":"JL Banks","year":"2005","unstructured":"Banks JL, Beard HS, Cao Y, Cho AE, Damm W, Farid R, Felts AK, Halgren TA, Mainz DT, Maple JR, Murphy R, Philipp DM, Repasky MP, Zhang LY, Berne BJ, Friesner RA, Gallicchio E, Levy RM (2005) Integrated modeling program, applied chemical theory (IMPACT). J Comput Chem 26(16):1752\u20131780","journal-title":"J Comput Chem"},{"issue":"21","key":"3954_CR41","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Mainz DT (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein\u2013ligand complexes. J Med Chem 49(21):6177\u20136196","journal-title":"J Med Chem"},{"issue":"8","key":"3954_CR42","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1021\/ci5002185","volume":"54","author":"S Sirin","year":"2014","unstructured":"Sirin S, Kumar R, Martinez C, Karmilowicz MJ, Ghosh P, Abramov YA, Sherman W (2014) A computational approach to enzyme design: predicting \u03c9-aminotransferase catalytic activity using docking and MM-GBSA scoring. J Chem Inf Model 54(8):2334\u20132346","journal-title":"J Chem Inf Model"},{"issue":"1-3","key":"3954_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0010-4655(95)00042-E","volume":"91","author":"HJ Berendsen","year":"1995","unstructured":"Berendsen HJ, van der Spoel D, van Drunen R (1995) GROMACS: a message-passing parallel molecular dynamics implementation. Comput Phys Commun 91(1-3):43\u201356","journal-title":"Comput Phys Commun"},{"key":"3954_CR44","unstructured":"Ebrahimi, Mohsen, et al. (2018) Structural Insight into Binding Mode of 9-Hydroxy Aristolochic Acid, Diclofenac and Indomethacin to PLA 2.\u00a0Interdisciplinary Sciences: Computational Life Sciences\u00a010(2):400\u2013410"},{"issue":"12","key":"3954_CR45","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","volume":"18","author":"B Hess","year":"1997","unstructured":"Hess B, Bekker H, Berendsen HJ, Fraaije JG (1997) LINCS: a linear constraint solver for molecular simulations. J Comput Chem 18(12):1463\u20131472","journal-title":"J Comput Chem"},{"issue":"6","key":"3954_CR46","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1021\/ct400045d","volume":"9","author":"I Maffucci","year":"2013","unstructured":"Maffucci I, Contini A (2013) Explicit ligand hydration shells improve the correlation between MM-PB\/GBSA binding energies and experimental activities. J Chem Theory Comput 9(6):2706\u20132717","journal-title":"J Chem Theory Comput"},{"issue":"11","key":"3954_CR47","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1021\/ci300385h","volume":"52","author":"HK Srivastava","year":"2012","unstructured":"Srivastava HK, Sastry GN (2012) Molecular dynamics investigation on a series of HIV protease inhibitors: assessing the performance of MM-PBSA and MM-GBSA approaches. J Chem Inf Model 52(11):3088\u20133098","journal-title":"J Chem Inf Model"},{"issue":"7","key":"3954_CR48","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1021\/jm301890k","volume":"56","author":"M Incerti","year":"2013","unstructured":"Incerti M, Tognolini M, Russo S, Pala D, Giorgio C, Hassan-Mohamed I, Noberini R, Pasquale EB, Vicini P, Piersanti S, Rivara S, Barocelli E, Mor M, Lodola A (2013) Amino acid conjugates of lithocholic acid as antagonists of the EphA2 receptor. J Med Chem 56(7):2936\u20132947","journal-title":"J Med Chem"},{"key":"3954_CR49","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/insr.12051_5","volume":"82","author":"F Durante","year":"2014","unstructured":"Durante F (2014) The R book, second edition by Michael J. Crawley. Int Stat Rev 82:145\u2013146. https:\/\/doi.org\/10.1111\/insr.12051_5","journal-title":"Int Stat Rev"},{"issue":"D1","key":"3954_CR50","doi-asserted-by":"publisher","first-page":"D380","DOI":"10.1093\/nar\/gkw952","volume":"45","author":"S Placzek","year":"2017","unstructured":"Placzek S, Schomburg I, Chang A, Jeske L, Ulbrich M, Tillack J, Schomburg D (2017) BRENDA in 2017: new perspectives and new tools in BRENDA. Nucleic Acids Res 45(D1):D380\u2013D388","journal-title":"Nucleic Acids Res"},{"key":"3954_CR51","unstructured":"Selvaraj, Chandrabose, et al (2011) Tool development for Prediction of pIC 50 values from the IC 50 values-A pIC 50 value calculator.\u00a0Current Trends in Biotechnology & Pharmacy\u00a05(2):1104\u20131109"},{"key":"3954_CR52","doi-asserted-by":"publisher","first-page":"S249","DOI":"10.1097\/00005344-199800001-00070","volume":"31","author":"LC Yang","year":"1998","unstructured":"Yang LC, Wang F, Liu M (1998) A study of an endothelin antagonist from a Chinese anti-snake venom medicinal herb. J Cardiovasc Pharmacol 31:S249\u2013S250","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"3954_CR53","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1747-0285.2007.00483.x","volume":"69","author":"T Halgren","year":"2007","unstructured":"Halgren T (2007) New method for fast and accurate binding site identification and analysis. Chem Biol Drug Des 69(2):146\u2013148","journal-title":"Chem Biol Drug Des"},{"issue":"8","key":"3954_CR54","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2174\/156802607780487614","volume":"7","author":"S Marcussi","year":"2007","unstructured":"Marcussi S, Sant\u2019Ana CD, Oliveira CZ, Quintero Rueda A, Menaldo DL, Beleboni RO, Stabeli RG, Giglio JR, Fontes M, Marcos R, Soares AM (2007) Snake venom phospholipase A2 inhibitors: medicinal chemistry and therapeutic potential. Curr Top Med Chem 7(8):743\u2013756","journal-title":"Curr Top Med Chem"},{"issue":"6","key":"3954_CR55","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/0006-2952(92)90381-R","volume":"44","author":"W Pruzanski","year":"1992","unstructured":"Pruzanski W, Greenwald RA, Street LP, Lauberte F, Stefanski E, Vadas P (1992) Inhibition of enzymatic activity of phospholipases A2 by minocycline and doxycycline. Biochem Pharmacol 44(6):1165\u20131170","journal-title":"Biochem Pharmacol"},{"issue":"2-4","key":"3954_CR56","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1023\/A:1025386326946","volume":"17","author":"A Golbraikh","year":"2003","unstructured":"Golbraikh A, Shen M, Xiao Z, Xiao YD, Lee KH, Tropsha A (2003) Rational selection of training and test sets for the development of validated QSAR models. J Comput Aided Mol Des 17(2-4):241\u2013253","journal-title":"J Comput Aided Mol Des"},{"issue":"1","key":"3954_CR57","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40360-018-0196-3","volume":"19","author":"K Kuca","year":"2018","unstructured":"Kuca K, Musilek K, Jun D, Zdarova-Karasova J, Nepovimova E, Soukup O, Hrabinova M, Mikler J, TCC F, EFF DC, De Castro AA, Valis M, Ramalho TC (2018) A newly developed oxime K203 is the most effective reactivator of tabun-inhibited acetylcholinesterase. BMC Pharmacol Toxicol 19(1):8","journal-title":"BMC Pharmacol Toxicol"},{"issue":"5","key":"3954_CR58","doi-asserted-by":"publisher","first-page":"360","DOI":"10.2174\/1570180812666150918191550","volume":"13","author":"WEA Lima de","year":"2016","unstructured":"de Lima WEA, Pereira AF, de Castro AA, da Cunha EFF, Ramalho TC (2016) Flexibility in the molecular design of acetylcholinesterase reactivators: probing representative conformations by chemometric techniques and docking\/QM calculations. Lett Drug Des Discov 13(5):360\u2013371","journal-title":"Lett Drug Des Discov"},{"issue":"1","key":"3954_CR59","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/toxins10010008","volume":"10","author":"P Ojeda","year":"2018","unstructured":"Ojeda P, Ram\u00edrez D, Alzate-Morales J, Caballero J, Kaas Q, Gonz\u00e1lez W (2018) Computational studies of snake venom toxins. Toxins 10(1):8","journal-title":"Toxins"},{"issue":"2","key":"3954_CR60","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/07391102.2013.765361","volume":"32","author":"A Silva Gon\u00e7alves da","year":"2014","unstructured":"da Silva Gon\u00e7alves A, Fran\u00e7a TCC, Caetano MS, Ramalho TC (2014) Reactivation steps by 2-PAM of tabun-inhibited human acetylcholinesterase: reducing the computational cost in hybrid QM\/MM methods. J Biomol Struct Dyn 32(2):301\u2013307","journal-title":"J Biomol Struct Dyn"},{"issue":"11","key":"3954_CR61","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3390\/toxins9110341","volume":"9","author":"TA Sales","year":"2017","unstructured":"Sales TA, Marcussi S, da Cunha EF, Kuca K, Ramalho TC (2017) Can inhibitors of snake venom phospholipases A2 lead to new insights into anti-inflammatory therapy in humans? A theoretical study. Toxins 9(11):341","journal-title":"Toxins"}],"container-title":["Journal of Molecular Modeling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-019-3954-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00894-019-3954-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-019-3954-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T07:46:13Z","timestamp":1694677573000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00894-019-3954-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,8]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["3954"],"URL":"https:\/\/doi.org\/10.1007\/s00894-019-3954-2","relation":{},"ISSN":["1610-2940","0948-5023"],"issn-type":[{"value":"1610-2940","type":"print"},{"value":"0948-5023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,8]]},"assertion":[{"value":"20 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"88"}}